ArticleThe oncologist2022

Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data.

James M Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.